pks13 Resolved · high auto-curated

H37Rv Rv3800c · MTBC0 mtbc0_004028 · 1733 aa · 4280055–4285256 MTBC0 (-) · RefSeq NP_218317.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)polyketide synthase
MTBC0 PGAP re-annotationpolyketide synthase Pks13
Revised (this work)Polyketide synthase Pks13. Pfam: PP-binding (PF00550.32), ketoacyl-synt (PF00109.33), Thiolase_N (PF00108.30), Ketoacyl-synt_C (PF02801.29), KAsynt_C_assoc (PF16197.12), Acyl_transf_1 (PF00698.27), Thioesterase (PF00975.27).
Functional category (TubercuList)lipid metabolism

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 82 publications

82 TB publications mention this gene. 82 publications discuss this gene. Queried separately, 78 records carry a M. tuberculosis context and 11 a non-TB mycobacterial context (species named in the 11-record verified sample: M. smegmatis (11), M. leprae (2)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 82: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Rational design of hybrid benzilmonoxime-thiocarbohydrazide Schiff bases as emerging anti-tubercular chemotypes: integrated biological and computational evaluation. doi:10.1016/j.bioorg.2026.110239 2026
Functional importance of Asp264 in the ketosynthase domain of Pks13 in Mycobacterium smegmatis. doi:10.1016/j.tcsw.2026.100178 2026
Large-Scale Chemical-Genetic Interaction Profiling Identifies a Small-Molecule Inhibitor of Mycobacterium tuberculosis Polyketide Synthase 13. doi:10.1021/acsinfecdis.6c00136 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation. doi:10.1038/s44321-026-00415-7 2026
Exquisite specificity of Pks13 defines the essentiality of trehalose in mycobacteria. doi:10.1073/pnas.2507896123 2026
82 records returned by the alias sweep

Searched as: Rv3800c, pks13, Mb3830c, ML0101, MMAR_5364, MSMEG_6392, MAB_0180 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Rational design of hybrid benzilmonoxime-thiocarbohydrazide Schiff bases as emerging anti-tubercular chemotypes: integrated biological and computational evaluation. doi:10.1016/j.bioorg.2026.110239 Bioorg Chem 2026
Functional importance of Asp264 in the ketosynthase domain of Pks13 in Mycobacterium smegmatis. doi:10.1016/j.tcsw.2026.100178 names it Cell Surf 2026
Large-Scale Chemical-Genetic Interaction Profiling Identifies a Small-Molecule Inhibitor of Mycobacterium tuberculosis Polyketide Synthase 13. doi:10.1021/acsinfecdis.6c00136 ACS Infect Dis 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation. doi:10.1038/s44321-026-00415-7 EMBO Mol Med 2026
Exquisite specificity of Pks13 defines the essentiality of trehalose in mycobacteria. doi:10.1073/pnas.2507896123 names it Proc Natl Acad Sci U S A 2026
Discovery of furo[2,3-b]isoquinoline derivatives as novel Pks13 inhibitors with reduced hERG inhibition. doi:10.1016/j.bmcl.2026.130561 names it Bioorg Med Chem Lett 2026
Novel pyrimido[1,2-a]imidazole derivatives as potent Pks13-TE inhibitors: structure-based virtual screening and rational design. doi:10.1039/d5md00942a names it RSC Med Chem 2026
Comparative transcriptomic signatures of virulent and attenuated Mycobacterium bovis growing in vitro and in mice. doi:10.3389/fcimb.2025.1643664 Front Cell Infect Microbiol 2025
Cytotoxic, Antibacterial, and in Silico Pks13 Inhibitory Properties of Indole-Coupled Dihydrobenzo[c]phenanthridines. doi:10.1002/cmdc.202500146 names it ChemMedChem 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13. doi:10.1038/s41586-025-09286-3 names it Nature 2025
A split ALFA tag-nanobody system for protein localization and proximity proteomics in mycobacteria. doi:10.1128/mbio.00971-25 mBio 2025
Suppressing lipid biosynthesis in Mycobacterium tuberculosis through polyketide synthase 13 thioesterase inhibition: Insights from computational analysis. doi:10.1016/j.jiph.2025.102835 J Infect Public Health 2025
Synthesis and evaluation of Trehalose-Pks13 inhibitor conjugates targeting mycobacteria. doi:10.1016/j.carres.2025.109506 names it Carbohydr Res 2025
Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy. doi:10.1021/acsinfecdis.4c01054 names it ACS Infect Dis 2025
Structure-based Virtual Screening and Hit Identification of Novel designed Quinazolin-4(3H)-one Derivatives as Antitubercular Agent against Targets Polyketide Synthase 13 and DNA gyrase of Mycobacterium tuberculosis. doi:10.2174/0115701638362095250402180030 Curr Drug Discov Technol 2025
A split ALFA tag-nanobody system for protein localization and proximity proteomics in mycobacteria. doi:10.1101/2025.03.22.644702 bioRxiv 2025
Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition. doi:10.1021/acs.jmedchem.4c02635 J Med Chem 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of Mycobacterium tuberculosis. doi:10.1021/acsinfecdis.4c00808 names it ACS Infect Dis 2025
Corrigendum to "Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis" [Europ. J. Med. Chem. 283 (2025) 117148]. doi:10.1016/j.ejmech.2025.117239 names it Eur J Med Chem 2025
Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis. doi:10.1016/j.ejmech.2024.117148 names it Eur J Med Chem 2025
Identification of BMVC-8C3O as a novel Pks13 inhibitor with anti-tuberculosis activity. doi:10.1016/j.tube.2024.102579 names it Tuberculosis (Edinb) 2025
New thiazolyl-isoxazole derivatives as potential anti-infective agents: design, synthesis, in vitro and in silico antimicrobial efficacy. doi:10.1080/07391102.2024.2306497 J Biomol Struct Dyn 2025
Cryo-electron microscopy structure of the di-domain core of Mycobacterium tuberculosis polyketide synthase 13, essential for mycobacterial mycolic acid synthesis. doi:10.1099/mic.0.001505 Microbiology (Reading) 2024
Polyketide Synthase 13 (Pks13) Inhibition: A Potential Target for New Class of Anti-tubercular Agents. doi:10.2174/0115680266322983240906055750 names it Curr Top Med Chem 2024
Identification of novel hit molecules targeting M. tuberculosis polyketide synthase 13 by combining generative AI and physics-based methods. doi:10.1016/j.compbiomed.2024.108573 Comput Biol Med 2024
Inhibitors of the Thioesterase Activity of Mycobacterium tuberculosis Pks13 Discovered Using DNA-Encoded Chemical Library Screening. doi:10.1021/acsinfecdis.3c00592 names it ACS Infect Dis 2024
Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. doi:10.1038/s41598-024-57124-9 names it Sci Rep 2024
19 Schiff bases as antimycobacterial agents: synthesis, molecular docking and a plausible mechanism of action. doi:10.4155/fmc-2023-0305 Future Med Chem 2024
Polyketide synthases mutation in tuberculosis transmission revealed by whole genomic sequence, China, 2011-2019. doi:10.3389/fgene.2023.1217255 Front Genet 2023
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity. doi:10.1021/acs.jmedchem.3c01514 J Med Chem 2023
Targeting polyketide synthase 13 for the treatment of tuberculosis. doi:10.1016/j.ejmech.2023.115702 Eur J Med Chem 2023
In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of M. tuberculosis Polyketide Synthase 13. doi:10.3390/ph16060829 Pharmaceuticals (Basel) 2023
Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain. doi:10.1016/j.compbiolchem.2023.107864 names it Comput Biol Chem 2023
Targeting mycobacterial membranes and membrane proteins: Progress and limitations. doi:10.1016/j.bmc.2023.117212 Bioorg Med Chem 2023
Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13. doi:10.1038/s41594-022-00918-0 names it Nat Struct Mol Biol 2023
Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13. doi:10.1101/2023.01.27.525930 names it bioRxiv 2023
Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis. doi:10.1128/AAC.02190-20 names it Antimicrob Agents Chemother 2023
Novel 1,2,3-Triazole-Based Benzothiazole Derivatives: Efficient Synthesis, DFT, Molecular Docking, and ADMET Studies. doi:10.3390/molecules27238555 Molecules 2022
Multi-omics Investigation into the Mechanism of Action of an Anti-tubercular Fatty Acid Analogue. doi:10.1021/jacs.2c08238 J Am Chem Soc 2022
Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment. doi:10.1021/acs.jmedchem.2c01064 names it J Med Chem 2022
Identification of novel inhibitors for mycobacterial polyketide synthase 13 via in silico drug screening assisted by the parallel compound screening with genetic algorithm-based programs. doi:10.1038/s41429-022-00549-z J Antibiot (Tokyo) 2022
Solution structure of the type I polyketide synthase Pks13 from Mycobacterium tuberculosis. doi:10.1186/s12915-022-01337-9 names it BMC Biol 2022
Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis. doi:10.3390/molecules27092844 names it Molecules 2022
Comparative Analysis on Proteomics Profiles of Intracellular and Extracellular M.tb and BCG From Infected Human Macrophages. doi:10.3389/fgene.2022.847838 Front Genet 2022
Mandelic acid-based spirothiazolidinones targeting M. tuberculosis: Synthesis, in vitro and in silico investigations. doi:10.1016/j.bioorg.2022.105688 Bioorg Chem 2022
Crystal structures of FadD32 and pks13-ACP domain from Corynebacterium diphtheriae. doi:10.1016/j.bbrc.2021.12.083 names it Biochem Biophys Res Commun 2022
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target. doi:10.1021/acs.jmedchem.1c01586 names it J Med Chem 2022
Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads. doi:10.1016/j.bioorg.2021.105110 Bioorg Chem 2021
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis. doi:10.1080/14756366.2021.1900162 J Enzyme Inhib Med Chem 2021
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules. doi:10.1016/j.ejmech.2021.113202 names it Eur J Med Chem 2021
Molecular Docking Suggests the Targets of Anti-Mycobacterial Natural Products. doi:10.3390/molecules26020475 Molecules 2021
Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis. doi:10.1016/j.ejmech.2020.112772 Eur J Med Chem 2020
Insights into structures of imidazo oxazines as potent polyketide synthase XIII inhibitors using molecular modeling techniques. doi:10.1080/10799893.2020.1742740 J Recept Signal Transduct Res 2020
Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem. doi:10.2174/1871526519666181205163810 Infect Disord Drug Targets 2020
Identification of novel scaffolds targeting Mycobacterium tuberculosis. doi:10.1007/s00109-019-01840-7 J Mol Med (Berl) 2019
Insights into an alternative benzofuran binding mode and novel scaffolds of polyketide synthase 13 inhibitors. doi:10.1007/s00894-019-4010-y J Mol Model 2019
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II. doi:10.1021/acs.jmedchem.9b00010 J Med Chem 2019
Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13. doi:10.1080/07391102.2018.1462734 J Biomol Struct Dyn 2019
Crystallization and structure analysis of the core motif of the Pks13 acyltransferase domain from Mycobacterium tuberculosis. doi:10.7717/peerj.4728 names it PeerJ 2018
Characterization of Tetrahydrolipstatin and Stereoderivatives on the Inhibition of Essential Mycobacterium tuberculosis Lipid Esterases. doi:10.1021/acs.biochem.8b00152 Biochemistry 2018
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. doi:10.1021/acs.jmedchem.7b01319 J Med Chem 2018
An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis. doi:10.1002/anie.201709365 Angew Chem Int Ed Engl 2018
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13. doi:10.1016/j.cell.2017.06.025 Cell 2017
Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis. doi:10.1074/jbc.M116.748053 J Biol Chem 2016
Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis. doi:10.1039/c6ob00821f Org Biomol Chem 2016
Sulphur-Containing Heterocycles as Antimycobacterial Agents: Recent Advances in Thiophene and Thiadiazole Derivatives. doi:10.2174/1568026616666160506131118 Curr Top Med Chem 2016
The polyketide synthase Pks13 catalyzes a novel mechanism of lipid transfer in mycobacteria. doi:10.1016/j.chembiol.2014.10.011 names it Chem Biol 2014
In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis. doi:10.3109/08820139.2013.857353 Immunol Invest 2014
New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics. doi:10.2174/1381612819666131118203641 Curr Pharm Des 2014
Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis? doi:10.1016/j.tube.2013.09.003 Tuberculosis (Edinb) 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. doi:10.1371/journal.pone.0075245 PLoS One 2013
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis. doi:10.1038/nchembio.1277 names it Nat Chem Biol 2013
Biochemical and structural study of the atypical acyltransferase domain from the mycobacterial polyketide synthase Pks13. doi:10.1074/jbc.M111.325639 names it J Biol Chem 2012
The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis. doi:10.1016/j.chembiol.2009.03.012 Chem Biol 2009
The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. doi:10.1074/jbc.M109.006940 names it J Biol Chem 2009
Hallmarks of mycolic acid biosynthesis: a comparative genomics study. doi:10.1002/prot.21591 Proteins 2007
The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. doi:10.1111/j.1365-2958.2007.05761.x Mol Microbiol 2007
Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs. doi:10.1371/journal.pcbi.0010046 PLoS Comput Biol 2005
The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions. doi:10.1016/j.jmb.2005.09.016 J Mol Biol 2005
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. doi:10.1128/CMR.18.1.81-101.2005 Clin Microbiol Rev 2005
The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components. doi:10.1074/jbc.M408578200 J Biol Chem 2005
A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. doi:10.1073/pnas.0305439101 Proc Natl Acad Sci U S A 2004

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbouraccD4 (Rv3799c, - strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): Fatty Acid Biosynthesis (trcR and Rv1776c and whiB4 ).

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

Post-translational modifications

2 reported modified residue(s), incl. 2 phosphosite(s): O-(pantetheine 4'-phosphoryl)serine @55, O-(pantetheine 4'-phosphoryl)serine @1266.

Experimentally reported post-translational modification(s). A phosphosite indicates the protein is expressed and is a substrate of the M. tuberculosis Ser/Thr/Tyr kinase signalling network — a regulatory context, NOT a molecular function. Source: UniProt (Modified residue features; PTM sites curated from the M. tuberculosis literature).

CRISPRi vulnerability

Vulnerability index -9.05 (95% CI -9.65 to -8.43). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in the final steps of mycolic acid biosynthesis. Catalyses the condensation of two fatty acyl chains.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3830c · 99.9% identity
M. leprae ML0101 · 83.5% identity
M. marinum MMAR_5364 · 83.9% identity
M. smegmatis MSMEG_6392 · 71.6% identity
M. orygis RJtmp_003912 · 99.9% identity
M. abscessus MAB_0180 · 69.4% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt I6X8D2 SwissProt · reviewed · Evidence at protein level
UniProt namePolyketide synthase Pks13
EC (curated) EC 2.3.1.-
Curated functionInvolved in the biosynthesis of mycolic acids. Forms, with FadD32, the initiation module of the mycolic condensation system. Synthesizes, in coupled reaction with FadD32, the biosynthetic precursors of mycolic acids, alpha-alkyl beta-ketoacids, via the condensation of two long chain fatty acid derivatives, a very long meromycoloyl-AMP and a shorter 2-carboxyacyl-CoA. The acyl chain of the acyl-AMP produced by FadD32 is specifically transferred onto the N-terminal ACP domain of Pks13, and then transferred onto the KS domain. The extender unit carboxyacyl-CoA is specifically loaded onto the AT d.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category Q Secondary metabolites biosynthesis, transport and catabolism
Preferred namepks13
eggNOG descriptionsynthase
Orthologous groupCOG0236
KEGG orthology K12437

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.364 · purifying
Polymorphic sites (≥ 0.1% of strains) 15 synonymous, 16 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Corynebacteriales

M. canettii dN/dS (deep-divergence selection) 0.064 · 19 consensus substitution(s)
under purifying selection vs M. canettii (deep divergence; dN/dS=0.064) — a real, constrained gene predating the MTBC clonal expansion
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 82.0% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 7/13 non-Mycobacterium reference genomes (down to Corynebacteriales) · mean identity 50.5%
detected across the order Corynebacteriales (Corynebacterium/Nocardia/Rhodococcus/…) but not in more distant Actinomycetia — a Corynebacteriales-level gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 58 in the ORF — 58 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.017, mean read count 1. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 58 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain validated drug target

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainpks-Teton1.1 (TetON promoter 1)
Baseline knockdown fitness2.68 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionyes (informs phenotypic-cluster / MOA assignment)
Drug-target cross-referenceannotated mechanism-of-action target Pks13: 4 reference compound(s) phenocopy its inhibition — chemically-validated druggable target

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Proteomics (mass spectrometry) detected

MS detectiondetected in 16 of 16 independent MS datasets
Integrated abundance2243.0 ppm · rank 63/3519 (98.2th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length1733 aa
Molecular weight186.4 kDa
Theoretical pI4.83
GRAVY-0.186 (hydrophilic)
Aliphatic index88.5
Aromaticity0.065
Instability index40.1 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
PP-bindingPF00550.32 1.8e-1025–91 Phosphopantetheine attachment site
ketoacyl-syntPF00109.33 1.4e-86118–366 Beta-ketoacyl synthase, N-terminal domain
Thiolase_NPF00108.30 5.0e-07277–316 Thiolase, N-terminal domain
Ketoacyl-synt_CPF02801.29 7.3e-44374–491 Beta-ketoacyl synthase, C-terminal domain
KAsynt_C_assocPF16197.12 1.4e-11494–553 Ketoacyl-synthetase C-terminal extension
Acyl_transf_1PF00698.27 5.5e-56713–1036 Acyl transferase domain
ThioesterasePF00975.27 7.6e-181470–1565 Thioesterase domain

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 9f48 (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 28 solved

PDBMethodResolutionCoverage
9f48 Electron Microscopy 3.4 Å 100%
9c0p X-ray diffraction 1.87 Å 28%
9c9o X-ray diffraction 2.02 Å 28%
9c1d X-ray diffraction 2.05 Å 28%
9c2r X-ray diffraction 2.18 Å 28%
9c1c X-ray diffraction 2.22 Å 28%
9c1v X-ray diffraction 2.57 Å 28%
8q17 X-ray diffraction 1.71 Å 16%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (28 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 83.2

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8cv1-assembly1_A 1.00 0.94 0.56 0.94 76% 61% / 100% 0.0e+00 sig 8cv1-assembly1_A ACP1-KS-AT domains of mycobacterial Pks13
9f48-assembly1_B 1.00 0.97 0.52 0.97 95% 56% / 100% 0.0e+00 sig 9f48-assembly1_B KS + AT di-domain of polyketide synthase 13 in Mycobacterium tuberculosis
9f48-assembly1_A 1.00 0.97 0.52 0.97 95% 56% / 100% 0.0e+00 sig 9f48-assembly1_A KS + AT di-domain of polyketide synthase 13 in Mycobacterium tuberculosis
8cuy-assembly1_B 1.00 0.96 0.52 0.96 77% 56% / 100% 0.0e+00 sig 8cuy-assembly1_B ACP1-KS-AT domains of mycobacterial Pks13
8cuz-assembly1_A 1.00 0.95 0.51 0.95 76% 56% / 100% 0.0e+00 sig 8cuz-assembly1_A KS-AT domains of mycobacterial Pks13 with inward AT conformation

Foldseek search of the AlphaFold DB model (mean pLDDT 83.2, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 3

Upstream (5' on genome)accD4 (- strand, -4 bp gap)
Downstream (3' on genome)fadD32 (- strand, 6 bp gap)
Predicted operon accD4 · pks13 · fadD32

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 3: accD4 · pks13 · fadD32 — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3907) exponential phase: operon of 3, Rv3799c · Rv3800c · Rv3801c (coverage 258.0)
stationary phase: operon of 3, Rv3799c · Rv3800c · Rv3801c (coverage 230.02) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: mbtH (hypothetical protein), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 378 partners at medium confidence (106 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. Of the 378 partners, 1 rest on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv2377c mbtH exp (transferred) hypothetical protein 999 1000 ctx neighborhood:400 coexpression:915 experimental:999 textmining:496
Rv2383c mbtB exp (transferred) phenyloxazoline synthase 999 1000 ctx neighborhood:544 coexpression:999 experimental:473 textmining:745
Rv2524c fas exp (transferred) curated paralog fatty acid synthase 999 1000 ctx neighborhood:544 coexpression:840 experimental:994 database:549 textmining:767
Rv0101 nrp exp (transferred) peptide synthetase Nrp 998 997 ctx neighborhood:544 coexpression:983 experimental:473 textmining:586
Rv3801c fadD32 long-chain-fatty-acid--AMP ligase FadD32 999 994 ctx neighborhood:881 cooccurence:413 coexpression:838 textmining:977
Rv3799c accD4 propionyl-CoA carboxylase subunit beta AccD 996 976 ctx neighborhood:881 coexpression:810 textmining:864
Rv2243 fabD exp (transferred) curated malonyl CoA-acyl carrier protein transacylase 987 976 coexpression:677 experimental:787 database:549 textmining:524
Rv1663 pks17 polyketide synthase 977 968 ctx fusion:688 cooccurence:758 coexpression:470
Rv2380c mbtE exp (transferred) peptide synthetase 979 965 ctx neighborhood:508 coexpression:805 experimental:473 textmining:435
Rv1527c pks5 exp (transferred) paralog polyketide synthase 987 959 ctx neighborhood:544 coexpression:803 experimental:414 textmining:720
Rv2940c mas exp (transferred) paralog multifunctional mycocerosic acid synthase 987 959 ctx neighborhood:544 coexpression:807 experimental:414 textmining:703
Rv3825c pks2 exp (transferred) paralog phthioceranic/hydroxyphthioceranic acid synthase 986 959 ctx neighborhood:544 coexpression:804 experimental:414 textmining:691
Rv2933 ppsC exp (transferred) paralog phthiocerol synthesis polyketide synthase type I PpsC 986 958 ctx neighborhood:544 coexpression:803 experimental:414 textmining:694
Rv2048c pks12 exp (transferred) paralog polyketide synthase 991 957 ctx neighborhood:544 coexpression:803 experimental:414 textmining:812
Rv2384 mbtA 2,3-dihydroxybenzoate-AMP ligase 969 940 coexpression:917 textmining:512

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: polyketide synthase
  • MTBC0 PGAP product: polyketide synthase Pks13
  • Pfam (hmmscan --cut_ga): PP-binding PF00550.32 (E=2e-10), ketoacyl-synt PF00109.33 (E=1e-86), Thiolase_N PF00108.30 (E=5e-07), Ketoacyl-synt_C PF02801.29 (E=7e-44), KAsynt_C_assoc PF16197.12 (E=1e-11), Acyl_transf_1 PF00698.27 (E=5e-56), Thioesterase PF00975.27 (E=8e-18)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218317.1)
  • Domains: Pfam-A via hmmscan --cut_ga — PP-binding (PF00550.32), ketoacyl-synt (PF00109.33), Thiolase_N (PF00108.30), Ketoacyl-synt_C (PF02801.29), KAsynt_C_assoc (PF16197.12), Acyl_transf_1 (PF00698.27), Thioesterase (PF00975.27)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0236
  • Curated reference: UniProt I6X8D2 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 83.2)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 378 functional partner(s); context anchor mbtH
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_004028|Rv3800c|pks13
MADVAESQENAPAERAELTVPEMRQWLRNWVGKAVGKAPDSIDESVPMVELGLSSRDAVAMAADIEDLTGVTLSVAVAFAHPTIESLATRIIEGEPETDLAGDDAEDWSRTGPAERVDIAIVGLSTRFPGEMNTPEQTWQALLEGRDGITDLPDGRWSEFLEEPRLAARVAGARTRGGYLKDIKGFDSEFFAVAKTEADNIDPQQRMALELTWEALEHARIPASSLRGQAVGVYIGSSTNDYSFLAVSDPTVAHPYAITGTSSSIIANRVSYFYDFHGPSVTIDTACSSSLVAIHQGVQALRNGEADVVVAGGVNALITPMVTLGFDEIGAVLAPDGRIKSFSADADGYTRSEGGGMLVLKRVDDARRDGDAILAVIAGSAVNHDGRSNGLIAPNQDAQADVLRRAYKDAGIDPRTVDYIEAHGTGTILGDPIEAEALGRVVGRGRPADRPALLGAVKTNVGHLESAAGAASMAKVVLALQHDKLPPSINFAGPSPYIDFDAMRLKMITTPTDWPRYGGYALAGVSSFGFGGANAHVVVREVLPRDVVEKEPEPEPEPKAAAEPAEAPTLAGHALRFDEFGNIITDSAVAEEPEPELPGVTEEALRLKEAALEELAAQEVTAPLVPLAVSAFLTSRKKAAAAELADWMQSPEGQASSLESIGRSLSRRNHGRSRAVVLAHDHDEAIKGLRAVAAGKQAPNVFSVDGPVTTGPVWVLAGFGAQHRKMGKSLYLRNEVFAAWIEKVDALVQDELGYSVLELILDDAQDYGIETTQVTIFAIQIALGELLRHHGAKPAAVIGQSLGEAASAYFAGGLSLRDATRAICSRSHLMGEGEAMLFGEYIRLMALVEYSADEIREVFSDFPDLEVCVYAAPTQTVIGGPPEQVDAILARAEAEGKFARKFATKGASHTSQMDPLLGELTAELQGIKPTSPTCGIFSTVHEGRYIKPGGEPIHDVEYWKKGLRHSVYFTHGIRNAVDSGHTTFLELAPNPVALMQVALTTADAGLHDAQLIPTLARKQDEVSSMVSTMAQLYVYGHDLDIRTLFSRASGPQDYANIPPTRFKRKEHWLPAHFSGDGSTYMPGTHVALPDGRHVWEYAPRDGNVDLAALVRAAAAHVLPDAQLTAAEQRAVPGDGARLVTTMTRHPGGASVQVHARIDESFTLVYDALVSRAGSESVLPTAVGAATAIAVADGAPVAPETPAEDADAETLSDSLTTRYMPSGMTRWSPDSGETIAERLGLIVGSAMGYEPEDLPWEVPLIELGLDSLMAVRIKNRVEYDFDLPPIQLTAVRDANLYNVEKLIEYAVEHRDEVQQLHEHQKTQTAEEIARAQAELLHGKVGKTEPVDSEAGVALPSPQNGEQPNPTGPALNVDVPPRDAAERVTFATWAIVTGKSPGGIFNELPRLDDEAAAKIAQRLSERAEGPITAEDVLTSSNIEALADKVRTYLEAGQIDGFVRTLRARPEAGGKVPVFVFHPAGGSTVVYEPLLGRLPADTPMYGFERVEGSIEERAQQYVPKLIEMQGDGPYVLVGWSLGGVLAYACAIGLRRLGKDVRFVGLIDAVRAGEEIPQTKEEIRKRWDRYAAFAEKTFNVTIPAIPYEQLEELDDEGQVRFVLDAVSQSGVQIPAGIIEHQRTSYLDNRAIDTAQIQPYDGHVTLYMADRYHDDAIMFEPRYAVRQPDGGWGEYVSDLEVVPIGGEHIQAIDEPIIAKVGEHMSRALGQIEADRTSEVGKQ